Crossmark

Riociguat for pulmonary arterial hypertension (PAH) associated with congenital heart disease (CHD): A subgroup analysis from the PATENT studies

Crossref DOI link: https://doi.org/10.1186/2050-6511-16-S1-A79

Published Online: 2015-09-02

Published Print: 2015-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Stephan, Rosenkranz

Ghofrani, Hossein-Ardeschir

Beghetti, Maurice

Ivy, Dunbar

Fritsch, Arno

Weimann, Gerrit

Saleh, Soundos

Apitz, Christian

Frey, Reiner
License Information

License valid from 2015-09-02
More Information

Article History

First Online: 2 September 2015